Researcher Profiles

Return to member profile

Howard L. Kaufman, MD, FACS

Publications since 2011

Kaufman, H. L. Precision Immunology: The Promise of Immunotherapy for the Treatment of Cancer. J Clin Oncol, In process, . (PMID: 25605852)

Goldufsky, J. Wood, S. Hajihossainlou, B. Rehman, T. Majdobeh, O. Kaufman, H. L. Ruby, C. E. Shafikhani, S. H. Pseudomonas aeruginosa Exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines. J Med Microbiol, In process, . (PMID: 25587079)

Zloza, A. Kim, D. W. Broucek, J. Schenkel, J. M. Kaufman, H. L. High-Dose IL-2 Induces Rapid Albumin Uptake by Endothelial Cells Through Src-Dependent Caveolae-Mediated Endocytosis. J Interferon Cytokine Res, 34:915-919, . (PMID: 24963699, PMCID: PMC4217041)

Lu, R. Wu, S. Zhang, Y. Xia, Y. Huelsmann, E. J. Lacek, A. T. Nabatiyan, A. Richards, M. H. Narasipura, S. D. Lutgen, V. Chen, H. Kaufman, H. L. Chen, D. Al-Harthi, L. Zloza, A. Sun, J. HIV Infection Accelerates Gastrointestinal Tumor Outgrowth in NSG-HuPBL Mice. AIDS Res Hum Retroviruses, 30:677-684, . (PMID: 24593860, PMCID: PMC4076996)

Kaufman, H. L. Kim, D. W. Kim-Schulze, S. Deraffele, G. Joagoda, M. C. Broucek, J. Zloza, A. Results of a Randomized Phase I Gene Therapy Clinical Trial of Non-oncolytic Fowlpox Viruses Encoding T cell Co-stimulatory Molecules. Hum Gene Ther, 25:452-460, . (PMID: 24484178, PMCID: PMC4027985)

Kaufman, H. L. Melanoma as a model for precision medicine in oncology. Lancet Oncol, 15:251-253, . (PMID: 24508105)

Zloza, A. Kim, D. W. Kim-Schulze, S. Jagoda, M. C. Monsurro, V. Marincola, F. M. Kaufman, H. L. Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses. J Immunother Cancer, 2:1, . (PMID: 24829758, PMCID: PMC4019911)

Kim, D. W. Zloza, A. Broucek, J. Schenkel, J. M. Ruby, C. Samaha, G. Kaufman, H. L. Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells. J Transl Med, 12:113, . (PMID: 24885155, PMCID: PMC4062649)

Kaufman, H. L. Ruby, C. E. Hughes, T. Slingluff, C. L. Jr Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma. J Immunother Cancer, 2:11, . (PMID: 24971166, PMCID: PMC4072479)

Wong, M. K. Kaufman, H. L. Daniels, G. A. McDermott, D. F. Aung, S. Lowder, J. N. Morse, M. A. Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes. J Immunother Cancer, 2:20, . (PMID: 25031835, PMCID: PMC4100489)

Kaufman, H. L. Wong, M. K. Daniels, G. A. McDermott, D. F. Aung, S. Lowder, J. N. Morse, M. A. The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2). J Pers Med, 4:52-64, . (PMID: 25562142)

Kaufman, H. L. Kirkwood, J. M. Hodi, F. S. Agarwala, S. Amatruda, T. Bines, S. D. Clark, J. I. Curti, B. Ernstoff, M. S. Gajewski, T. Gonzalez, R. Hyde, L. J. Lawson, D. Lotze, M. Lutzky, J. Margolin, K. McDermott, D. F. Morton, D. Pavlick, A. Richards, J. M. Sharfman, W. Sondak, V. K. Sosman, J. Steel, S. Tarhini, A. Thompson, J. A. Titze, J. Urba, W. White, R. Atkins, M. B. The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma. Nat Rev Clin Oncol, 10:588-598, . (PMID: 23982524)